piRABC and TNFSF4 as biomarkers for diagnosis and staging of bladder cancer.

Clinical Utility of PCA3 Assay in Patients with Suspicious Prostate Cancer

The value of various prostate cancer tumor markers in early detection, diagnosis, follow up and monitoring of the treatment

Evaluation of the diagnostic performance of serum P53 protein for the diagnosis of colorectal cancer.

CLINICOPATHOLOGICAL SIGNIFICANCE OF PROGRAMED DEATH -LIGAND -1(PD-L1) AND PROLIFERATION CELL NUCLEAR ANTIGE(PCNA)EXPRESSION IN PROSTATIC CARCINOMA; AN IMMUNOHISTOCHEMICAL STUDY"

Progastrin releasing peptide as a tumor marker for cancer prostate

Soluble urokinase-type plasminogen activator receptor as a diagnostic biomarker for sepsis in intensive care unit patients

Evaluation of chromogranin A as atumor marker for cancer prostate

Theranostics in Prostate Cancer.

The value of STEAP1, C-myc and P63 Immuno-expression in differentiation of prostatic carcinoma from its mimickers